Advertisement

High-Frequency Low-Penetrance Alleles

  • Paul Pharoah
Chapter
Part of the Cancer Genetics book series (CANGENETICS)

Abstract

Breast cancer, like other common cancers, tends to cluster in families, with disease being approximately twofold more common in first-degree relatives of cases [1–3]. The higher rate of most cancers in the monozygotic twins of cases than in dizygotic twins or siblings suggests that most of the familial clustering is the result of genetic variation rather than lifestyle or environmental factors [4,5]. Furthermore, simulation studies have shown that even if an environmental factor is perfectly correlated among relatives, it needs to confer at least a 10-fold increase in risk to result in even modest increases in familial relative risk

Keywords

Breast Cancer Risk Allele Candidate Gene Study Polygenic Model CHEK2 1100delc 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Pharoah PDP, Day NE, Duffy S, Easton DF, Ponder BAJ. Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 1997; 71:800–9.CrossRefPubMedGoogle Scholar
  2. 2.
    Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 2001; 358:1389–99.CrossRefGoogle Scholar
  3. 3.
    Amundadottir LT, Thorvaldsson S, Gudbjartsson DF, et al. Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PLoS Med 2004; 1:e65.CrossRefPubMedGoogle Scholar
  4. 4.
    Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer – analyses of cohorts of twins from Sweden, Denmark and Finland. N Engl J Med 2000; 343:78–85.CrossRefPubMedGoogle Scholar
  5. 5.
    Peto J, Mack TM. High constant incidence in twins and other relatives of women with breast cancer. Nat Genet 2000; 26:411–4.CrossRefPubMedGoogle Scholar
  6. 6.
    Hopper JL, Carlin JB. Familial aggregation of a disease consequent upon correlation between relatives in a risk factor measured on a continuous scale. Am J Epidemiol 1992; 136:1138–47.PubMedGoogle Scholar
  7. 7.
    Easton DF. How many more breast cancer predisposition genes are there? Breast Cancer Res 1999; 1:14–7.CrossRefPubMedGoogle Scholar
  8. 8.
    Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 1998; 62:676–89.CrossRefPubMedGoogle Scholar
  9. 9.
    Smith P, McGuffog L, Easton DF, et al. A genome wide linkage search for breast cancer susceptibility genes. Genes Chromosomes Cancer 2006; 45:646–55.CrossRefPubMedGoogle Scholar
  10. 10.
    Antoniou AC, Pharoah PDP, McMullen G, et al. A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer 2002; 86:76–83.CrossRefPubMedGoogle Scholar
  11. 11.
    Wang WY, Barratt BJ, Clayton DG, Todd JA. Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet 2005; 6:109–18.CrossRefPubMedGoogle Scholar
  12. 12.
    Pharoah PDP, Dunning AM, Ponder BAJ, Easton DF. Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer 2004; 4:850–60.CrossRefPubMedGoogle Scholar
  13. 13.
    Bell DW, Varley JM, Szydlo TE, et al. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science 1999; 286:2528–31.CrossRefPubMedGoogle Scholar
  14. 14.
    Meijers-Heijboer H, van den Ouweland A, Klijn J, et al. Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 2002; 31:55–9.CrossRefPubMedGoogle Scholar
  15. 15.
    Vahteristo P, Bartkova J, Eerola H, et al. A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet 2002; 71:432–8.CrossRefPubMedGoogle Scholar
  16. 16.
    CHEK2 Breast Cancer Case–Control Consortium, Pharoah PDP. CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from nine studies. Am J Hum Genet 2004; 74:1175–82.CrossRefGoogle Scholar
  17. 17.
    Renwick A, Thompson D, Seal S, et al. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet 2006; 38:873–5.CrossRefPubMedGoogle Scholar
  18. 18.
    Seal S, Thompson D, Renwick A, et al. Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet 2006; 38:1239–41.CrossRefPubMedGoogle Scholar
  19. 19.
    Rahman N, Seal S, Thompson D, et al. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 2007; 39:165–7.CrossRefPubMedGoogle Scholar
  20. 20.
    MacPherson G, Healey CS, Teare MD, et al. Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J Natl Cancer Inst 2004; 96:1866–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Frank B, Bermejo JL, Hemminki K, et al. Re: association of a common variant of the CASP8 gene with reduced risk of breast cancer. J Natl Cancer Inst 2005; 97:1012; author reply 1012–3.PubMedGoogle Scholar
  22. 22.
    Cox A, Dunning AM, Garcia-Closas M, et al. A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet 2007; 39:352–8.CrossRefPubMedGoogle Scholar
  23. 23.
    Easton DF, Pooley KA, Dunning AM, et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007; 447:1087–93.CrossRefPubMedGoogle Scholar
  24. 24.
    Hunter DJ, Kraft P, Jacobs KB, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 2007.Google Scholar
  25. 25.
    Stacey SN, Manolescu A, Sulem P, et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 2007; 39:865–9.CrossRefPubMedGoogle Scholar
  26. 26.
    Garcia-Closas M, Hall P, Nevanlinna H, et al. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet 2008; 4e1000054.Google Scholar
  27. 27.
    Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407:770–6.CrossRefPubMedGoogle Scholar
  28. 28.
    Adnane J, Gaudray P, Dionne CA, et al. BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers. Oncogene 1991; 6:659–63.PubMedGoogle Scholar
  29. 29.
    Moffa AB, Tannheimer SL, Ethier SP. Transforming potential of alternatively spliced variants of fibroblast growth factor receptor 2 in human mammary epithelial cells. Mol Cancer Res 2004; 2:643–52.PubMedGoogle Scholar
  30. 30.
    Jang JH, Shin KH, Park JG. Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers. Cancer Res 2001; 61:3541–3.PubMedGoogle Scholar
  31. 31.
    Greenman C, Stephens P, Smith R, et al. Patterns of somatic mutation in human cancer genomes. Nature 2007; 446:153–8.CrossRefPubMedGoogle Scholar
  32. 32.
    Smid M, Wang Y, Klijn JG, et al. Genes associated with breast cancer metastatic to bone. J Clin Oncol 2006; 24:2261–7.CrossRefPubMedGoogle Scholar
  33. 33.
    Pharoah PDP, Antoniou A, Bobrow M, Zimmern RL, Ponder BAJ, Easton DF. Polygenic susceptibility to breast cancer: implications for prevention. Nature Genet 2002; 31:33–6.CrossRefPubMedGoogle Scholar
  34. 34.
    Antoniou AC, Easton DF. Polygenic inheritance of breast cancer: Implications for design of association studies. Genet Epidemiol 2003; 25:190–202.CrossRefPubMedGoogle Scholar
  35. 35.
    Vineis P, Schulte P, McMichael AJ. Misconceptions about the use of genetic tests in populations. Lancet 2001; 357:709–12.CrossRefPubMedGoogle Scholar
  36. 36.
    Antoniou AC, Durocher F, Smith P, Simard J, Easton DF. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families. Breast Cancer Res 2006; 8:R3.CrossRefPubMedGoogle Scholar
  37. 37.
    Pharoah PDP, Mackay J. Absolute risk of breast cancer in women at increased risk: a more useful clinical measure than relative risk? The Breast 1998; 7:255–9.CrossRefGoogle Scholar
  38. 38.
    Ioannidis JP. Why most published research findings are false? PLoS Med 2005; 2:e124.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Department of OncologyUniversity of CambridgeCambridgeUK

Personalised recommendations